Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H28Cl2FNO5 |
Molecular Weight | 476.366 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12C[C@@H](OCC3=CC=C(Cl)C(Cl)=C3)[C@@](N)(C(O)=O)[C@]1([H])[C@@]2(F)C(=O)OCCCCCCC
InChI
InChIKey=SVZJNGHWEHDHLT-OUSKECTQSA-N
InChI=1S/C22H28Cl2FNO5/c1-2-3-4-5-6-9-30-20(29)21(25)14-11-17(22(26,18(14)21)19(27)28)31-12-13-7-8-15(23)16(24)10-13/h7-8,10,14,17-18H,2-6,9,11-12,26H2,1H3,(H,27,28)/t14-,17-,18+,21-,22+/m1/s1
Molecular Formula | C22H28Cl2FNO5 |
Molecular Weight | 476.366 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Synthesis, in vitro pharmacology, structure-activity relationships, and pharmacokinetics of 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent and selective group II metabotropic glutamate receptor antagonists. | 2004 Aug 26 |
|
MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity. | 2004 Mar |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:08:49 GMT 2023
by
admin
on
Sat Dec 16 10:08:49 GMT 2023
|
Record UNII |
12XH8EKL2A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
12XH8EKL2A
Created by
admin on Sat Dec 16 10:08:49 GMT 2023 , Edited by admin on Sat Dec 16 10:08:49 GMT 2023
|
PRIMARY | |||
|
11641449
Created by
admin on Sat Dec 16 10:08:49 GMT 2023 , Edited by admin on Sat Dec 16 10:08:49 GMT 2023
|
PRIMARY | |||
|
820244-38-0
Created by
admin on Sat Dec 16 10:08:49 GMT 2023 , Edited by admin on Sat Dec 16 10:08:49 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PRODRUG |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Actually, BCI-838 is a "prodrug." It gets converted to its active form, BCI-632, only after being metabolized in the body. BCI-632 blocks proteins in the brain known as Group II metabotropic glutamate receptors. These receptors normally bind with glutamate, a neurotransmitter that is abundant in the brain, to enable memory and other brain functions.
|